• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Videolaparoscopic Splenectomy for Malignant Hematologic Disease of the Spleen: The Therapy of Choice? A Retrospective Series of 55 Cases.

Videolaparoscopic Splenectomy for Malignant Hematologic Disease of the Spleen: The Therapy of Choice? A Retrospective Series of 55 Cases.

Roberta Gelmini, MD, PhD, *Fabrizio Romano, MD, Francesco Serrra, MD, *Fabio Uggeri, MD, Chiara Franzoni, MD, *Arianna L. Ciravegna, MD, *Franco Uggeri, MD

Department of Surgery, Policlinico di Modena University of Modena and Reggio Emilia – *Department of Surgery, San Gerardo Hospital II University of Milan – Bicocca

INTRODUCTION: Nowadays, Laparoscopic Splenectomy (LS) is considered the treatment of choice for the benign hematologic diseases of the spleen. However the role of LS in malignant hematologic diseases is still controversial. Technical difficulties related to splenomegaly, splenic ilum enlarged nodes and consequent hemorrhagic risk, the need of pathological characterization of malignant disease on entire removed spleen, should be considered contraindications to LS in malignancies. The aim of this study is to compare efficacy and feasibility of LS for hematologic malignancies and patients outcome with benign disease patients who underwent the same procedure.

METHODS AND PROCEDURES: Between January 2001 and May 2012 in two affiliated university hospitals, 117 patients underwent to LS for hematologic disease. Retrospectively, patients were shared in two groups: group A (62 pz.) with preoperative diagnosis of benign hematologic disease and group B (55 pz.) with malignancies. For each group were evaluated bipolar spleen diameter, mean operative time, conversion rate and causes, postoperative complications and need of transfusion. The statistical analysis was realized with Fisher exact test and Mann-Whitney U test using the open source program “Openstat” by WG Miller – June 2012.

RESULTS: Median splenic diameter was greater in group B (mean 17,05 cm) than in group A (mean 14,45 cm) with a statistically significant difference (p<0.005), such as higher were the number of accessory mini-laparotomy (group B=52,72% vs A=17,74% p<0,005)) and conversion rate (B= 18,18% vs A4,83% p=0,022) in the group of patients with diagnosis of malignancy. The mean operative time was 123,87 min. in group A and 148,1 min. in group B (p<0,005). Besides, there weren’t significant differences about the need to intra-operative and post-operative transfusions and incidence of post-operative complications among the two groups of patients. No mortality occurred.

CONCLUSIONS: The analysis of our data highlights that LS for hematologic malignancies is effective and feasible even if associated to a higher conversion rate compared with LS for benign disorders due to splenomegaly and difficult ilum dissection, more frequent in malignancies. Besides, no differences in the outcome of patients (blood loss, morbility and mortality) was noted among the two groups. We can conclude that LS as to be considered a safe procedure in treatment of hematological malignancies of the spleen as stated in the EAES consensus statement on laparoscopic splenectomy (2008)


Session: Poster Presentation

Program Number: P664

61

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals